Navigation Links
Arthrosurface Hits a $100 Million Milestone
Date:4/23/2012

FRANKLIN, Mass., April 23, 2012 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that, in March, it surpassed $100 Million in cumulative net revenue. While this milestone is a significant financial achievement for the Company, its management believes that this milestone evidences the ever growing population of patients seeking alternatives to total joint replacement procedures. "Joint preservation, getting patients back to an active lifestyle and delaying conventional joint replacements has been our goal from the beginning," said Steve Ek, COO.

Arthrosurface contends it is the first and only company to develop a line of anatomic inlay implants for early joint disease and remains the leader in patient-matching metallic resurfacing. With more than 160 different implant sizes and shapes, the Arthrosurface joint platform could be considered the best first implant for early joint arthritis. Its resurfacing implants are thin, contoured, sized according to the defect and shaped to the patient's native joint surface. It is believed that there is no other orthopaedics company in the world with products that allow surgeons to intraoperatively and directly assess the joint status and choose a matching implant that, during the surgical procedure, serves the specific clinical need of the patient. With Arthrosurface's HemiCAP® resurfacing, the implant is matched to the patient. This implant-fitting concept is contrary to standard joint replacement where the patient is "fitted" to an implant through a series of large bone and soft tissue cuts.

Arthrosurface's President, Steve Tallarida, said, "We knew the idea of intervening sooner rather than later, when joint damage is limited, went against the conventional wisdom of traditional orthopaedics. In the world of total joints, treatment is typically delayed until significant joint destruction has occurred. We decided to take our cue from other disciplines, such as cardiology and dentistry, where stents and fillings are the first line choices for early intervention. Patients should have the option of considering an interim treatment in order to resume a normal lifestyle while hopefully delaying joint disease progression." 


'/>"/>
SOURCE Arthrosurface, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthrosurface Crosses the 30,000 Patient and 100 Publication Milestones
2. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
3. Arthrosurface Continues to Expand into Fast Growing Shoulder Market
4. Arthrosurface® Hits the 20,000 Implant Milestone
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. Delcath Systems, Inc. Secures $20 Million Credit Facility
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource
9. Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
10. Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million
11. Nile Therapeutics, Inc. to Raise $1.4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016 In a historic vote among its ... to construct a medical cannabis cultivation facility and dispensary on tribal land ... New York as a provider for patients in the state,s ... as a provider for patients in the state,s Medical Cannabis ... (34) to approve the project and pursue designation from the ...
(Date:2/8/2016)...   Intarcia Therapeutics, Inc. today announced the ... the newly created role of Vice President, Head of ... two decades of leadership experience at leading pharmaceutical, biotechnology, ... medical center. Most recently Dr. Yee served as VP, ... Head Medical Officer at AstraZeneca, where he led medical ...
(Date:2/8/2016)... PAOLI, Pa. , Feb. 8, 2016  As part ... Ltd has announced today the appointment of Lori Chmura ... more than 20 years in the industry, Chmura,s extensive experience ... in the advancement of Dune Medical Devices. ... Lori will be responsible for leading all sales, marketing and ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... newly redesigned website, federallabs.org . The site houses a wealth of federal ... federal technologies through the process called technology transfer (T2). As a network of ...
(Date:2/8/2016)... ... , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other tokens ... This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store bought ... remind them of the lives they’ve led and the people they’ve touched. , ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley Rubber Corporation ... to provide its range of unique and advantaged protective solutions to a ... will provide bilingual customer service and marketing support. A new distribution center in ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated companies ... Gary D. Radine, who recently retired as president and CEO of Delta Dental of ... CEO of the Year , helped lead the effort to raise funds for studies ...
(Date:2/8/2016)... ... February 08, 2016 , ... FileHold's document management software ... provides a cloud hosted environment for FileHold software that is pay per user ... party applications using the FileHold web services API. DocuSyst also advises clients on ...
Breaking Medicine News(10 mins):